johnson-&-johnson-tops-profit-estimates-but-trims-full-year-outlook

Johnson & Johnson Tops Profit Estimates but Trims Full-Year Outlook

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/johnson-and-johnson-earnings-51658162214


  • Order Reprints

  • Print Article



Johnson & Johnson


reported second-quarter adjusted earnings of $2.59 a share, topping analysts’ estimates, but the healthcare giant trimmed its fiscal-year adjusted earnings outlook.



Johnson & Johnson


(ticker: JNJ) shares were up 0.7% in premarket trading Tuesday to $175.42.